Ad is loading...
GFVRX
Price
$17.44
Change
+$0.01 (+0.06%)
Updated
Nov 26 closing price
VFINX
Price
$556.72
Change
+$3.20 (+0.58%)
Updated
Nov 26 closing price
Ad is loading...

GFVRX vs VFINX

Header iconGFVRX vs VFINX Comparison
Open Charts GFVRX vs VFINXBanner chart's image
Goldman Sachs Focused Value R
Price$17.44
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$556.72
Change+$3.20 (+0.58%)
VolumeN/A
CapitalizationN/A
GFVRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFVRX vs. VFINX commentary
Nov 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVRX is a StrongBuy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. GFVRX (58.5M). VFINX pays higher dividends than GFVRX: VFINX (1.24) vs GFVRX (0.82). GFVRX was incepted earlier than VFINX: GFVRX (9 years) vs VFINX (48 years). GFVRX is a more actively managed with annual turnover of: 82.00 vs. VFINX (2.00). GFVRX (0) and VFINX (0) have matching initial minimum investment requirements. GFVRX annual gain was more profitable for investors over the last year : 32.73 vs. VFINX (30.95). VFINX return over 5 years is better than : 89.23 vs. GFVRX (54.59).
GFVRXVFINXGFVRX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years48 years-
Gain YTD23.91125.44994%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets58.5M1.28T0%
Annual Yield % from dividends0.821.2466%
Returns for 1 year32.7330.95106%
Returns for 3 years19.3129.9664%
Returns for 5 years54.5989.2361%
Returns for 10 yearsN/A190.19-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS23.691.40
+6.28%
Pharvaris NV
ONTF6.610.18
+2.80%
ON24
ASH79.770.72
+0.91%
Ashland
AME197.12-0.26
-0.13%
Ametek
LUMO4.30-0.01
-0.23%
Lumos Pharma